Brokerages Set Globe Life Inc. (NYSE:GL) Price Target at $133.10

Globe Life Inc. (NYSE:GL) has been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $135.50.

GL has been the topic of several recent analyst reports. BMO Capital Markets initiated coverage on Globe Life in a research report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 target price on the stock. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $132.00 to $143.00 in a report on Wednesday, January 8th. Keefe, Bruyette & Woods raised their target price on Globe Life from $137.00 to $145.00 and gave the company an “outperform” rating in a report on Wednesday, February 12th. Jefferies Financial Group upped their price target on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research note on Tuesday, December 10th. Finally, Wells Fargo & Company raised their price objective on shares of Globe Life from $126.00 to $141.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th.

Globe Life Price Performance

Shares of GL opened at $122.52 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. Globe Life has a 1-year low of $38.95 and a 1-year high of $132.00. The stock has a market cap of $10.28 billion, a PE ratio of 10.25 and a beta of 0.81. The firm has a fifty day moving average price of $116.53 and a 200 day moving average price of $109.35.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. As a group, sell-side analysts anticipate that Globe Life will post 13.87 EPS for the current year.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 14,340 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the completion of the sale, the chief executive officer now directly owns 16,396 shares in the company, valued at $1,783,884.80. This represents a 46.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mark A. Blinn sold 3,000 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now owns 5,122 shares of the company’s stock, valued at approximately $579,964.06. The trade was a 36.94 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,678 shares of company stock valued at $8,799,822. Corporate insiders own 1.51% of the company’s stock.

Institutional Investors Weigh In On Globe Life

A number of institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its stake in Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock worth $27,000 after buying an additional 194 shares in the last quarter. Albion Financial Group UT bought a new position in shares of Globe Life during the 4th quarter worth about $28,000. Rakuten Securities Inc. acquired a new stake in shares of Globe Life during the 4th quarter valued at about $28,000. Avalon Trust Co bought a new stake in Globe Life in the fourth quarter valued at about $41,000. Finally, EverSource Wealth Advisors LLC increased its stake in Globe Life by 32.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.